| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |